Current Trends and Future Perspectives in the Treatment of Pulmonary Hypertension: WHO Group II-V

Sukhdeep Bhogal, Debabrata Mukherjee, Subhash Banerjee, AKM Monwarul Islam, Ramesh Daggubati, Timir K. Paul

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

Pulmonary hypertension continues to be a life-threatening illness with debilitating physical and emotional consequences affecting around 1% of global population. The progression of this devastating disease is characterized by increase in pulmonary vascular resistance resulting in elevated pulmonary pressure, eventually leading to right heart failure and death. Better understanding of pathophysiology has led to substantial improvements in terms of availability of treatment options. The purpose of this review is to summarize the currently available treatment options along with pertinent trials and possible future therapies of pulmonary hypertension group II-V.

Original languageEnglish (US)
Pages (from-to)217-231
Number of pages15
JournalCurrent Problems in Cardiology
Volume43
Issue number5
DOIs
StatePublished - May 1 2018

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Current Trends and Future Perspectives in the Treatment of Pulmonary Hypertension: WHO Group II-V'. Together they form a unique fingerprint.

  • Cite this